To award task order E06 entitled "custom screening assays for metabolic stability and peptidase selectivity" in the base amount of $359,026.82.

Ended Awarded Last action

Contract number
75N93020F00002
Awardee
Awarding agency
Obligated
$396,701

Award facts

Opportunity
Contract value 63% obligated
  • $396,700.78 Current, with exercised options
  • $630,834.06 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
St Peters, MO 63304, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00003 -$2,463
Exercise an Option P00002 · Non-good laboratory practices (non-GLP) off-the shelf in vitro adme and safety screening assays to profile the metabolic stability and target selectivity… $24,082
Exercise an Option P00001 · The purpose of this modification is to exercise quantity options 1.1, and 1.2. Beginning with the effective date of this modification, the total fixed price… $16,055
Original award $359,027

About this award

Written by GovTribe AI ·

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Task Order E06 "Custom Screening Assays for Metabolic Stability and Peptidase Selectivity" to Eurofins Panlabs, Inc. for $359,026.82 on a firm fixed price basis. This task order is part of the Nonclinical Services for Development of Interventional Agents indefinite delivery/indefinite quantity (IDIQ) contract. Eurofins Panlabs, Inc. is a contract research organization that provides analytical chemistry, microbiology, and toxicology testing services to support research programs across various federal agencies. The potential value of this task order is $630,834.06, and it does not have a set-aside designation.

Subawards

Subcontractor Amount Awarded
University Of Vermont & State Agricultural College THIS TASK ORDER IS FOR THE EVALUATION OF SAFETY AND IMMUNOGENICITY OF LIVE-ATTENUATED PEDIATRIC RSV VACCINE CANDIDATE DNS/D1313/I1334L, DELIVERED AS NASAL… $684,182
University Of Rochester EVALUATION OF SAFETY AND IMMUNOGENICITY OF LIVE-ATTENUATED PEDIATRIC RSV VACCINE CANDIDATE. The Contractor shall perform a Phase I clinical study to evaluate… $846,366
Charles River Laboratories Montréal ULC TASK ORDER B-1, ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING OF CANDIDATE MCMS Provide NHP samples to NIAID investigators for the discovery of… $1,148,699
Baylor College Of Medicine EVALUATION OF SAFETY AND IMMUNOGENICITY OF LIVE-ATTENUATED PEDIATRIC RSV VACCINE CANDIDATE. Design and conduct clinical trials $822,909

Quick answers

Who was awarded contract 75N93020F00002?

75N93020F00002 was awarded to Eurofins Discovery Services North America, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on November 11, 2019.

How much is contract 75N93020F00002 worth?

The government has obligated $396,701 on 75N93020F00002. Its potential value, with all options, is $630,834.

Is contract 75N93020F00002 an order under another contract?

Yes. 75N93020F00002 is a delivery order under 75N93018D00007, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.

Was contract 75N93020F00002 competed?

The extent of competition for 75N93020F00002 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login